Impact of Immune Response in Short-term and Long-term Outcomes After Minimally Invasive Surgery for Colorectal Liver Metastases: Results From a Randomized Study-Reference-Cited by-同舟云学术

Impact of Immune Response in Short-term and Long-term Outcomes After Minimally Invasive Surgery for Colorectal Liver Metastases: Results From a Randomized Study

Published:2021-07-21 Issue:6 Volume:31 Page:690-696
ISSN:1534-4908
Container-title:Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
language:en
Short-container-title:

Author:

Lopez-Lopez Victor,Gómez Ruiz Alvaro,Pelegrin Pablo,Abellán Beatriz,Lopez-Conesa Asunción,Brusadin Roberto,Cayuela Valentin,García Ana,Robles Campos Ricardo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference33 articles.

1. Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM;Vera;Clin Transl Oncol,2020

2. Laparoscopic liver resection: a review of current indications and surgical techniques;Jia;Hepatobiliary Surg Nutr,2018

3. Changes in T-lymphocytes’ viability after laparoscopic versus open cholecystectomy;Gomatos;Int Surg,2015

4. Inflammatory response in laparoscopic vs. open surgery for gastric cancer;Okholm;Scand J Gastroenterol,2014

5. ERAS protocol reduces IL-6 secretion in colorectal laparoscopic surgery: results from a randomized clinical trial;Mari;Surg Laparosc Endosc Percutan Tech,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Inflammation in Oncologic Patients Undergoing Systemic Treatment and Receiving Whey Protein-Based Nutritional Support;International Journal of Molecular Sciences;2024-05-27

2. Minimally Invasive Surgery in Liver Transplantation: From Living Liver Donation to Graft Implantation;Livers;2024-02-17

3. Minimally invasive surgery and liver transplantation: is it a safe, feasible, and effective approach?;Updates in Surgery;2023-04-04

4. Analgesia and stress attenuation of ultrasound‐guided modified pectoral nerve block type‐II with different volumes of 0.3% ropivacaine in patients undergoing modified radical mastectomy for breast cancer: A prospective parallel randomized double‐blind controlled clinical trial;Journal of Clinical Pharmacy and Therapeutics;2022-06-28